We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+14.5%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$59B
AUM Growth
+$9.67B
Cap. Flow
+$3.02B
Cap. Flow %
5.11%
Top 10 Hldgs %
26.45%
Holding
2,790
New
663
Increased
538
Reduced
776
Closed
680

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$905M
2
NVDA icon
NVIDIA
NVDA
+$592M
3
AMD icon
Advanced Micro Devices
AMD
+$439M
4
AMGN icon
Amgen
AMGN
+$385M
5
ADBE icon
Adobe
ADBE
+$382M

Sector Composition

Rank Sector Weight
1 Technology 14.79%
2 Consumer Discretionary 13.23%
3 Healthcare 12.61%
4 Financials 7.44%
5 Communication Services 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMRN icon
276
BioMarin Pharmaceuticals
BMRN
$11.5B
$41.6M 0.07%
431,343
+223,656
+108% +$19.8M
FDX icon
277
FedEx
FDX
$74.5B
$41.6M 0.07%
164,389
-351,250
-68% -$89.2M
WFC icon
278
Wells Fargo
WFC
$261B
$41.3M 0.07%
838,495
+570,860
+213% +$24.6M
TREX icon
279
Trex
TREX
$4.51B
$41.3M 0.07%
498,357
+231,096
+86% +$15.3M
UEC icon
280
Uranium Energy
UEC
$4.71B
$41M 0.07%
6,401,315
-343,390
-5% -$2.05M
XRAY icon
281
Dentsply Sirona
XRAY
$2.59B
$40.8M 0.07%
+1,147,056
New +$36.4M
WWD icon
282
Woodward
WWD
$25B
$40.6M 0.07%
298,237
+47,983
+19% +$6.27M
K
283
DELISTED
Kellanova
K
$40.6M 0.07%
726,032
+511,488
+238% +$26.7M
RPRX icon
284
Royalty Pharma
RPRX
$26.1B
$40.5M 0.07%
1,440,043
+1,275,233
+774% +$35M
MMYT icon
285
MakeMyTrip
MMYT
$4.67B
$40.2M 0.07%
856,646
-477,207
-36% -$20.1M
JPM icon
286
CALL
JPMorgan Chase
JPM
$939B
$39.6M 0.07%
232,600
+193,300
+492% +$29.3M
AMGN icon
287
Amgen
AMGN
$203B
$39.5M 0.07%
137,041
-1,411,187
-91% -$385M
KO icon
288
Coca-Cola
KO
$354B
$39.4M 0.07%
668,447
-235,382
-26% -$13.4M
SJM icon
289
J.M. Smucker
SJM
$12.6B
$39.2M 0.07%
310,090
-25,719
-8% -$2.98M
LIVN icon
290
LivaNova
LIVN
$4.3B
$39.2M 0.07%
757,097
-133,506
-15% -$6.46M
COUR icon
291
Coursera
COUR
$1.54B
$38.8M 0.07%
2,002,603
+247,393
+14% +$4.73M
AMED
292
DELISTED
Amedisys
AMED
$38.7M 0.07%
406,628
+92,485
+29% +$8.64M
TSM icon
293
TSMC
TSM
$2.09T
$38.2M 0.06%
367,583
-93,480
-20% -$8.91M
X
294
DELISTED
US Steel
X
$38M 0.06%
781,099
-1,275,482
-62% -$46.4M
CMA
295
DELISTED
Comerica
CMA
$37.9M 0.06%
679,337
+122,100
+22% +$5.52M
LYV icon
296
Live Nation Entertainment
LYV
$41.2B
$37.8M 0.06%
403,334
+348,073
+630% +$30M
XLY icon
297
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.4B
$37.7M 0.06%
421,200
+88,800
+27% +$7.35M
ADM icon
298
Archer Daniels Midland
ADM
$41.4B
$37.4M 0.06%
517,871
+351,579
+211% +$25.7M
TCOM icon
299
Trip.com Group
TCOM
$27.5B
$37.4M 0.06%
1,037,356
-1,618,655
-61% -$55.2M
HSIC icon
300
Henry Schein
HSIC
$9.74B
$37.3M 0.06%
492,165
+193,641
+65% +$13.5M

Similar funds

Marshall Wace's Q4 2023 Portfolio in Review

As of Q4 2023, Marshall Wace held 2,790 positions worth $59B, up 20% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Marshall Wace deployed $3.02B of net new capital in Q4 2023, opening 663 new positions and adding to 538 existing holdings. Its largest new stake was Qualcomm: 1,674,985 shares worth $242M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $905M trimmed.

  • Marshall Wace's largest Q4 2023 buy was Qualcomm: 1,674,985 shares worth $242M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $3.43B increase.
  • Marshall Wace's biggest Q4 2023 reduction was Microsoft, cutting an estimated $905M.
  • Marshall Wace fully exited VMware, Inc in Q4 2023, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 26% of its $59B portfolio in Q4 2023.
  • Marshall Wace opened 663 new positions and closed 680 in Q4 2023.
  • Marshall Wace's portfolio value rose 20% quarter-over-quarter to $59B.

Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.